Bariatric Surgery Improves Adipose Tissue Function

This article originally appeared here.
Share this content:
Bariatric Surgery Improves Adipose Tissue Function
Bariatric Surgery Improves Adipose Tissue Function

MONDAY, June 20, 2016 (HealthDay News) -- Bariatric surgery is associated with improvements in adipose tissue function, some of which are independent of weight loss, according to research published online June 8 in Obesity Reviews.

Henriette Frikke-Schmidt, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined how altered physiology of adipose tissue may contribute to the metabolic effects of bariatric surgery.

The researchers found that altered physiology of adipose tissue has specific effects on various fat depots, the function of individual adipocytes, and the interaction between adipose tissue and other metabolic tissues. Bariatric surgery alters the distribution of fat in addition to loss of fat mass, with fat shifting from visceral to the subcutaneous compartment favoring metabolic improvement. Furthermore, there were improvements in sensitivity toward lipolysis controlled by insulin and catecholamines, alterations in adipokine secretion, and decreases in local adipose inflammation and systemic inflammatory markers. Some of these changes were independent of weight loss and these effects could be explained by alterations in bile acid metabolism, gut microbiota, and central regulation of metabolism.

"In conclusion, bariatric surgery is capable of improving aspects of adipose tissue function and do so in some cases in ways that are not entirely explained by the potent effect of surgery," the authors write.

Several authors disclosed financial ties to the pharmaceutical, medical device, and nutrition industries.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »